Will Stone
Will Stone is a former reporter at KUNR Public Radio.
-
The burning questions: What makes this newly identified variant so transmissible? And what does it mean for preventing spread? -
Understaffed hospitals are already coping with increased patient demand heading into the holidays. They have few options to expand if omicron creates a huge new wave of COVID patients. -
Many U.S. hospitals are already struggling with a wave of COVID-19 patients and now they are also racing to prepare for the omicron variant, which threatens to further accelerate hospitalizations.
-
Pfizer's CEO says the vaccine maker has asked federal regulators to authorize boosters for 16- and 17-year-olds. Currently, only people 18 and over are eligible for a booster in the U.S. -
Booster shots have been authorized for all U.S. adults, and the government is urging people to get them. But what if you've already had COVID and the vaccine? -
The FDA plans to authorize Pfizer's COVID vaccine boosters for all adults 18 and older. The announcement could happen Thursday. What is the evidence for boosting younger healthier people?
-
After declining most of the fall, new infections are up again in more than half of U.S. states, worrying experts about what the holiday season may bring. -
The U.S. is entering an uneasy stretch of the pandemic. Despite progress, the delta surge is dragging on in certain regions. Can vaccines ward off a big surge over the holidays? -
You've seen the headlines about COVID boosters. But what does it all mean for you? Here's how to sort through the science and figure out if and when you need a booster and which one to get. -
With high-profile stories of vaccinated people dying from COVID, how worried should you be about getting a serious breakthrough case? Here's how the data shake out.
